Trade CBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Crescent Biopharma, Inc. (CBIO) is trading at US$14.91, up 5.59% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$637.02M. Over the past 52 weeks, CBIO has traded between US$8.72 and US$27.41. On Syfe you can trade CBIO with $0 commission and add it to your watchlist.
| Previous close | US$14.12 |
|---|---|
| Market cap | US$637.02M |
| 52-week range | US$8.72 – US$27.41 |
| Volume | 347.12K |
| Exchange | US |
Crescent Biopharma, Inc.
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
Year: 2025
Crescent Biopharma Closes $143.7 Million Public Offering
Jul 16, 8:22 PM · MT Newswires
Crescent Biopharma Prices $125 Million Common, Warrant Offering
Jul 15, 7:52 AM · MT Newswires
Crescent Biopharma, Inc. (CBIO) stock is trading at US$14.91, +5.59% from the previous close of US$14.12.
The market cap for Crescent Biopharma, Inc. (CBIO) stock is approximately US$637.02M.
The 52-week high for Crescent Biopharma, Inc. (CBIO) stock is US$27.41.
The 52-week low for Crescent Biopharma, Inc. (CBIO) stock is US$8.72.
Crescent Biopharma, Inc. (CBIO) does not currently pay a dividend.
Stay on top of CBIO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
